Evidence map›Paper›PMID 27843296›Full record

ArticleDrug design, development and therapy2016

Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells.

Binbing Ling, Deborah Michel, Meena Kishore Sakharkar, Jian Yang

Open access · goldAbstract readComparative Study
In one paragraph

Article in Drug design, development and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. The Analyses of Chemical Components FromFrontiers in pharmacology · 2021
    Article
  8. Article
  9. Probing the Antitumor Mechanism ofBioengineering (Basel, Switzerland) · 2019
    Article
  10. Article
  11. Inhibitory Effect ofBioMed research international · 2019
    Article
  12. African Nightshade (Nutrients · 2018
    Article
  13. Interspecies Anticancer and Antimicrobial Activities of GenusEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Binbing LingDrug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK; Department of Biomedical and Molecular Sciences, Queen's University, Cancer Biology & Genetics Division, Queen's Cancer Research Institute, Kingston, ON, Canada.
Deborah MichelDrug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK.
Meena Kishore SakharkarDrug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK.
Jian YangDrug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK.
University of Saskatchewan · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant melanoma (MM) is the most dangerous type of skin cancer, killing more than 1,100 people each year in Canada. Prognosis for late stage and recurrent MM is extremely poor due to insensitivity to chemotherapy drugs, and thus many patients seek complementary and alternative medicines. In this study, we examined four commonly used anticancer herbs in traditional Chinese medicine,

Indexed as

HedyotisLobeliaScutellariaSolanum nigrumAntineoplastic Agents, AlkylatingAntineoplastic Agents, PhytogenicAntineoplastic Combined Chemotherapy ProtocolsAntioxidantsCell Line, TumorChromatography, High Pressure LiquidDacarbazineDose-Response Relationship, DrugDrug SynergismHumansMelanomaPhytotherapyAntineoplastic Agents, AlkylatingAntineoplastic Agents, PhytogenicAntioxidantsDacarbazinePlant ExtractsReactive Oxygen SpeciesSolventsTemozolomideWatercytotoxicityherbal extractHPLC-MS/MSmalignant melanomareactive oxygen species

Identifiers

PMID27843296
PMCPMC5098531
OpenAlexW2548371687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.